• Big Pharma found to influence guideline writers, patient advocacy groups and doctors
    A series of papers on money and influence have unlocked the Pandora’s box of the pharmaceutical industry's influence on medicine and healthcare. The recent studies showed that they influence those who write guidelines that outline doctors' practices, patient advocacy organisations, letter writers to the CDC, and even oncologists on Twitter.
  • Singapore's MOH lauds efforts towards efficient and improved patient care
    Singapore's Ministry of Health is emphasising efforts to improve productivity at all levels of healthcare services to achieve greater efficiency and improve the quality of patient care.
  • Trump's vague healthcare decisions on the eve of his inauguration
    Donald Trump will be installed into the White House on 20 January. While he has assured Americans that his new healthcare plan would be much more affordable and cover all citizens, the vagueness of his plans raises much doubt. Will there be a favourable solution?
  • Health officers offered contract positions by Malaysia’s MOH
    The Ministry of Health is offering contract posts for doctors, dentists and pharmacists are being offered contracts to reduce the long waiting time for postings.
  • Singapore's public healthcare system to regroup into three integrated clusters
    The Singaporean Ministry of Health announced that the healthcare system will be reorganised into three integrated clusters, from the existing six regional health systems. This is said to better meet Singaporeans' future healthcare needs.
  • Shortage of beds and staff in NHS leads to cancelled ops for cancer patients
    Since Christmas last year, it was reported that 264 doctors have registered with the General Medical Council to work abroad. This comes after experts warned that any cold snap would tip the UK health service - which is already "a national disaster" - over the edge.
  • The no-suicide contract: does it help?
    Seven Hong Kong students committed suicide in nine days in March 2016, piquing the public’s interest about government measures in place to prevent such a crisis. As such, the Education Bureau initiated the creation of a ‘no-suicide contract’ and included it in an 88-page handbook distributed to schools for dealing with issues such as depression.
  • How bad is the counterfeit drug problem in Malaysia?
    Unfortunately, the issue of availability of counterfeit drugs is widespread within the Asia Pacific region, including Malaysia. To combat such an issue, the relevant stakeholders including pharmacists should have at least a basic understanding of the situation.
  • Duke-NUS researchers identify gene that could be partly responsible for autism
    A Singaporean team has identified a gene that could play a key role in causing autism. Changes in the gene cause the brain's circuitry and how its cells communicate with each other to work abnormally.
  • Hong Kong's war against antibiotic-resistant superbugs
    Healthcare professionals are obliged to treat patients with the best treatment they deem necessary - the most comprehensive diagnostic tests, the strongest and most effective drugs, and the best available care that patients wish to receive. But, are the perceived 'best' treatments always necessary?